Yazhen Qin Selected Research

Yazhen Qin Research Topics

9	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023 - 01/2011
4	Residual Neoplasm 05/2021 - 01/2018
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2018 - 02/2014
3	Philadelphia Chromosome 03/2024 - 02/2014
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2023 - 07/2009
2	Acute Promyelocytic Leukemia 04/2018 - 07/2009
2	Multiple Myeloma 01/2014 - 09/2013
1	Splenomegaly 01/2020
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2019
1	Aplastic Anemia (Anemia, Hypoplastic) 12/2019
1	Wilms Tumor (Wilm's Tumor) 12/2019
1	Acute Monocytic Leukemia (Acute Monoblastic Leukemia) 04/2018
1	Leukemia 01/2018
1	Blast Crisis (Blast Phase) 01/2016
1	Sepsis (Septicemia) 10/2015
1	Melanoma (Melanoma, Malignant) 01/2014
1	Testicular Neoplasms (Testicular Cancer) 01/2014

7	Tyrosine Kinase InhibitorsIBA 01/2023 - 02/2014
4	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 01/2011
3	olverembatinibIBA 01/2023 - 01/2022
2	Core Binding Factors (Core-Binding Factor)IBA 10/2023 - 05/2021
1	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2023
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 10/2023
1	AclarubicinIBA 10/2023
1	HomoharringtonineIBA 10/2023
1	Messenger RNA (mRNA)IBA 12/2019
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 09/2018
1	nilotinib FDA Link 01/2016
1	Dasatinib (BMS 354825)FDA Link 01/2016
1	AntigensIBA 01/2014
1	Bortezomib (Velcade)FDA Link 01/2014
1	CXCR4 Receptors (CXCR4 Receptor)IBA 09/2013
1	Indicators and Reagents (Reagents)IBA 09/2013
1	Phosphotransferases (Kinase)IBA 01/2011

6	Therapeutics 03/2024 - 07/2009
3	Hematopoietic Stem Cell Transplantation 09/2018 - 08/2015
2	Drug Therapy (Chemotherapy) 10/2015 - 02/2014
1	Stem Cell Transplantation 03/2024
1	Induction Chemotherapy 10/2023
1	Consolidation Chemotherapy 01/2021
1	Transplantation 10/2015